Fairvalue-Calculator Fairvalue-Calculator
EN DE

Cyclopharm Limited (CYC) Fair Value & Analysis

Healthcare · AU · Market cap A$79.4M

PriceA$0.5450
Fair ValueA$0.9700
Upside+78.0%
Quality95/100
Evidence: Low Range A$0.7300 – A$1.21

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Cyclopharm Limited (CYC) currently trades at A$0.5450, while our model-based Fair Value estimate is A$0.9700 — implying the stock looks roughly 78.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) +22% Cencora, Inc (C1CO34) -44% Cardinal Health, Inc (CAH) -49% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +112%

Frequently asked questions

Is Cyclopharm Limited (CYC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of A$0.9700 versus a price of A$0.5450 — about +78% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CYC?
Our 21-model fair value for Cyclopharm Limited is A$0.9700 (as of Jun 24, 2026), built from audited fundamentals. The current price is A$0.5450.
What is the quality score of CYC?
Cyclopharm Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.